92 related articles for article (PubMed ID: 10891290)
1. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
[TBL] [Abstract][Full Text] [Related]
2. New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer.
Rakowicz-Szulczynska EM; Markowski M; Mackiewicz A; Karczewska A; Snyder W; McIntosh DG; Kapcinska M; Smith ML
Cancer Lett; 1997 Jan; 112(1):93-101. PubMed ID: 9029174
[TBL] [Abstract][Full Text] [Related]
3. Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.
Rakowicz-Szulczynska EM
Clin Diagn Lab Immunol; 2000 May; 7(3):360-5. PubMed ID: 10799446
[TBL] [Abstract][Full Text] [Related]
4. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
5. Gp96 and its different expression in breast carcinomas.
Hodorova I; Rybarova S; Solar P; Vecanova J; Prokopcakova L; Bohus P; Solarova Z; Mellova Y; Schmidtova K
Neoplasma; 2008; 55(1):31-5. PubMed ID: 18190237
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.
Cance WG; Harris JE; Iacocca MV; Roche E; Yang X; Chang J; Simkins S; Xu L
Clin Cancer Res; 2000 Jun; 6(6):2417-23. PubMed ID: 10873094
[TBL] [Abstract][Full Text] [Related]
7. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
10. Expression of periostin in human breast cancer.
Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
[TBL] [Abstract][Full Text] [Related]
11. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
12. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
13. CD109 expression in basal-like breast carcinoma.
Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of ras p21 oncoprotein in breast cancer imprints.
Agnantis NJ; Apostolikas NA; Zolotas VG; Spandidos DA
Acta Cytol; 1994; 38(3):335-40. PubMed ID: 8191822
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
Kuo SJ; Wang BB; Chang CS; Chen TH; Yeh KT; Lee DJ; Yin PL; Chen M
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622
[TBL] [Abstract][Full Text] [Related]
17. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
20. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]